| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/02/2005 | CA2446939C Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 08/02/2005 | CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| 08/02/2005 | CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | WO2005068455A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/28/2005 | WO2005068454A1 Indolylmaleimide derivatives |
| 07/28/2005 | WO2005068452A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/28/2005 | WO2005068448A1 Sulfonamides antagonising n-type calcium channels |
| 07/28/2005 | WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | WO2005068433A1 Benzimidazole derivatives |
| 07/28/2005 | WO2005068424A1 Indolinone derivatives as receptor tyrosine kinase ihibitors |
| 07/28/2005 | WO2005068074A2 Use of metal complex compounds comprising pyridine pryimidine or s-triazne derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acid and h2o2 |
| 07/28/2005 | WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | WO2005067644A2 Conjugated small molecules |
| 07/28/2005 | WO2005042517A3 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 07/28/2005 | WO2005033073A3 Spirocyclic heterocyclic derivatives and methods of their use |
| 07/28/2005 | WO2005032490A3 Cyclic diamines and derivatives as factor xa inhibitors |
| 07/28/2005 | WO2004060306A3 Anti-inflammatory medicaments |
| 07/28/2005 | US20050165065 N-type calcium channel blockers |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165062 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165061 Method for the purification of lansoprazole |
| 07/28/2005 | US20050165060 Mixture with solvent, or mixture thereof, with water; adding acid; isolation; crystallization |
| 07/28/2005 | US20050165059 anhydrous crystals containing less than about 0.1% (wt/wt) water; obtained from solvent extraction with solvents in the presence of amines, then adding acids and isolating the proton pump ihibitor |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165057 cholesterol acyl transferase inhibitor for treatment of hyperlipidemia and atherosclerosis; piperidin-4-yl]methyl urea derivatives |
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
| 07/28/2005 | US20050165035 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; 4-(3-chloro-2-fluoroanilino)-6-[1-(hydroxyacetyl)piperidin-4-yloxy]-7-methoxyquinazoline |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165033 mediated by prostaglandin D2, a ligand for orphan receptor CRTH2; rhinitis; N-substituted by a benzothiazolyl, a pyrimidinyl, an imidazolyl, an oxazolyl, or a thiazolyl |
| 07/28/2005 | US20050165032 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165015 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050165014 1 4-dihydro-1 4-diphenylpyridine derivatives |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 07/28/2005 | US20050164868 Non-heating clay composites for building materials |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2553200A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | CA2552740A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/28/2005 | CA2552738A1 Indolylmaleimide derivatives |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/28/2005 | CA2551948A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/28/2005 | CA2551495A1 Conjugated small molecules |
| 07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/27/2005 | EP1557414A1 Isoquinoline compounds and medicinal use thereof |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1557168A2 Biarylurea Derivatives |
| 07/27/2005 | EP1556467A1 Use of metal complex compounds as oxidation catalysts |
| 07/27/2005 | EP1556390A2 Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | EP1556381A1 Pyrazole amides for treating hiv infections |
| 07/27/2005 | EP1556379A2 Chemical compounds |
| 07/27/2005 | EP1556373A1 Cannabinoid receptor ligands and uses thereof |
| 07/27/2005 | EP1556372A2 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 07/27/2005 | EP1556371A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 07/27/2005 | EP1556370A1 Method for the synthesis of a benzimidazole compound |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556361A2 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 07/27/2005 | EP1556358A2 Enantioselective alkylation of tricyclic compounds |
| 07/27/2005 | EP1556357A1 Compounds, compositions, and methods |
| 07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 07/27/2005 | EP1556355A1 Inhibitors of glycogen synthase kinase 3 |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556351A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556348A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
| 07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/27/2005 | EP1556046A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 07/27/2005 | EP1556043A1 Amorphous form of esomeprazole salts |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1387837B1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1343766B1 Cyclization process step in the making of quinolones and naphthyridines |
| 07/27/2005 | EP1318992B1 Imidazole derivatives as raf kinase inhibitors |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1248622B1 Pharmaceutical composition comprising a metabolite of buspirone |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1165738B1 Composition and method for bleaching a substrate |
| 07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 07/27/2005 | EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/27/2005 | EP0929526B1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |